Author:
Lee Dae Ho,Choi Chang-Min,Kim Sang-We,Suh Cheolwon,Lee Jung-Shin
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference17 articles.
1. Bunn PA, Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions. Clin Cancer Res. 1998;4:1087–100.
2. Barlesi F, Jacot W, Astoul P, et al. Second-line treatment for advanced non-small cell lung cancer: a systemic review. Lung Cancer. 2006;51:159–72.
3. Azzoli CG, Giaccone G, Temin S. American society of clinical oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Oncol Pract. 2010;6:39–43.
4. Rusthoven J, Eisenhauer E, Butts C, et al. Multitargeted antifolate, LY231514, as first-line chemotherapy for patients with advanced nonsmall- cell lung cancer: a phase II study. J Clin Oncol. 1999;17:1194–9.
5. Clarke SJ, Abratt R, Goedhals L, et al. Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naive patients with advanced non-small cell lung cancer. Ann Oncol. 2002;13:737–41.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献